Because of its defined molecular profile, the compound is frequently used in laboratory studies examining peptide signalling and regulatory processes
Here are some of the most cited benefits with quantitative evidence: Increased Procollagen Synthesis: Studies showed topical GHK-Cu increased procollagen production in 70% of subjects, outperforming Vitamin C (50%) and tretinoin (40%)
John Wright at Washington State University as part of a systematic investigation into the cognitive-enhancing properties of the angiotensin IV/AT4 receptor system
Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2
For topical use, delivery vehicle matters as much as peptide purity
Still, there are cases where B12 injections are the better bet